J Korean Surg Soc.  2000 Oct;59(4):458-462.

Preliminary Result of Concurrent Chemotherapy and Radiotherapy in Stage I and II Breast Cancer Patients Treated with Breast Conservation Surgery

Affiliations
  • 1Department of Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea.
  • 2Department of Radiation Oncology, Inje University Sanggye Paik Hospital, Seoul, Korea.
  • 3Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea.

Abstract

PURPOSE: Breast conserving surgery is increasingly performed in early stage breast cancer patients. A certain propotion of these patients are at substantial risk for systemic metastasis. However, there is no valid consensus about optimal sequencing of chemotherapy and radiation therapy. METHODS: We conducted a randomized prospective study to investigate whether concurrent chemotherapy and radiation therapy after breast conserving surgery are associated with increased toxicity. Fifty-seven patients with stage I or II breast cancer were randomly assigned to receive CMF chemotherpy either simultaneously with (n=37) or before (n=20) radiation therapy. RESULTS: Moist desquamation was the most common adverse effect which occurred in 46% (16/37) of the patients treated with concurrent chemotherapy and radiation therapy and 40% (8/20) of those treated with the sequential regimen. This difference between two groups was not statistically significant. Also the incidence of severe neutropenia (WBC<1,800) or abnormal elevation of liver enzymes was not influenced by the sequencing of the adjuvant therapies. Arm edema was observed in 2 patients of the concurrent group and in 2 patients of the sequential regimen. Two patients treated with the concurrent regimen did not complete 6 cycles of chemotherapy while only one patient treated with sequential regimen did not. The incidence of toxicity during chemotherapy was not altered by the timing of radiation therapy. CONCLUSION: Chemotherapy and radiation therapy can be given concurrently after breast conserving surgery in stage I or II breast cancer patients without increase in serious toxicity.

Keyword

Breast cancer; Conservation surgery; Chemotherapy; Radiation therapy; Toxicity

MeSH Terms

Arm
Breast Neoplasms*
Breast*
Consensus
Drug Therapy*
Edema
Humans
Incidence
Liver
Mastectomy, Segmental
Neoplasm Metastasis
Neutropenia
Prospective Studies
Radiotherapy*
Full Text Links
  • JKSS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr